NCT07748065Completed
Effect of Intra-Dialytic Muscle Energy Technique on Restless Leg Syndrome in Hemodialysis Patients
Source: ClinicalTrials.gov · Last updated 5 Aug 2026
Brief summary (registry, in English)
The goal of this clinical trial is to learn if intra-dialytic Muscle Energy Technique (MET) can reduce symptoms of restless legs syndrome (RLS) in people with end-stage renal disease (ESRD) receiving maintenance hemodialysis. The study also aims to learn if this treatment can improve sleep quality, muscle strength, blood pressure, and oxygen saturation. The main questions it aims to answer are: * Does intra-dialytic Muscle Energy Technique reduce the severity of restless legs syndrome? * Does intra-dialytic Muscle Energy Technique improve sleep quality, muscle strength, blood pressure, and oxygen saturation? Researchers compared people who received intra-dialytic Muscle Energy Technique together with routine medical treatment and hemodialysis with people who received routine medical treatment and hemodialysis alone to find out whether adding Muscle Energy Technique provides greater benefits. Participants: * Were randomly placed into one of two groups. * Received routine medical treatment and hemodialysis. * Received intra-dialytic Muscle Energy Technique during the second hour of hemodialysis if they were in the intervention group. * Had three treatment sessions each week for eight weeks. * Had assessments before and after the eight-week treatment.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 30 Jul 2026
- Start date
- 1 Aug 2025
- Primary completion date
- 30 Apr 2026
- Lead sponsor
- Cairo University
- Diseases
- Chronic kidney disease
- NCT number
- NCT07748065
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 1 Aug 2025 to the primary completion date, 30 Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Receiving muscle relaxant medications.
Other illness
- Neurological disorders (e.g., stroke or head injury) associated with chronic pain.
- Uncontrolled pulmonary disease.
- Cognitive impairment or mental disorders that prevented participation in the intervention.
- Malignant disease.
- Unstable angina, uncontrolled cardiac arrhythmia, decompensated heart failure, acute pericarditis, or myocarditis.
- Hearing impairment.
Other
- Resting systolic blood pressure \>200 mmHg and/or diastolic blood pressure \>120 mmHg.
- Missed more than two weeks of the intervention program or withdrew from the study.
- Severe obesity.
Who the study is looking for
- Age 55 to 65 years.
- Diagnosed with end-stage renal disease (ESRD).
- Receiving maintenance hemodialysis three times per week for at least one year, with each session lasting approximately 4 hours.
- Diagnosed with restless legs syndrome using the International Restless Legs Syndrome Study Group (IRLSSG) Rating Scale.
- Under regular medical care.
- Body mass index (BMI) between 25.8 and 28.8 kg/m².
- Men and women were eligible.
Age in the registry: 55 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tala Central Hospital Coordinator of this site? Confirm its status | Tala | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.